Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study
Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people: systematic review and economic evaluation
Adalimumab for Uveitis in Juvenile Idiopathic Arthritis Reply
Adalimumab for Uveitis in Juvenile Idiopathic Arthritis
Adalimumab Monotherapy and a Combination with Azathioprine for Crohn's Disease: A Prospective, Randomized Trial
Adalimumab for Treatment of Noninfectious Uveitis Immunogenicity and Clinical Relevance of Measuring Serum Drug Levels and Antidrug Antibodies
Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa A Parallel Randomized Trial
Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial
Adalimumab as Steroid-Sparing Treatment of Inflammatory-Stage Thyroid Eye Disease
Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's disease
Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn%26apos;s Disease: Data From the EXTEND Trial
Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis Reply
Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn%26apos;s disease: Results from CARE
Adalimumab achieves three key treatment goals for patients with rheumatoid arthritis
Adalimumab for Treatment of Moderate to Severe Chronic Plaque Psoriasis of the Hands and Feet Efficacy and Safety Results From REACH, a Randomized, Placebo-Controlled, Double-blind Trial
Adalimumab in Severe and Acute Sciatica A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Adalimumab-associated antiphospholipid syndrome: a case report and review of the literature
Adalimumab in Treatment-Resistant Hidradenitis Suppurativa following Recurrence after Extensive Affected Area Excision: A Review of Biologics Therapy
Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease
Adalimumab in the Treatment of Uveitis in Juvenile Idiopathic Arthritis
Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapy
Adalimumab therapy-a double-edged sword?
Adalimumab-associated Pulmonary Cryptococcosis
Adalimumab in ulcerative colitis: hypes and hopes
Adalimumab for recurrent orbital myositis in Crohn's disease: Report of a case with a 3-year follow-up
Adalimumab for Pyoderma Gangrenosum Associated with Inflammatory Bowel Disease
Adalimumab as second line anti-tumour necrosis factor alpha therapy for Crohn's disease: A single centre experience
Adalimumab real-world dosage pattern and predictors of weekly dosing: Patients with Crohn's disease in the United States
Adalimumab-Induced Disseminated Superficial Porokeratosis
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation
Adalimumab for the Treatment of Pityriasis Rubra Pilaris: A Case Report
Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis
Adalimumab for psoriasis in Greece: clinical experience in a tertiary referral centre
Adalimumab in the treatment of rheumatoid arthritis
Adalimumab treatment may replace or enhance the activity of steroids in steroid-refractory tuberculous meningitis
Adalimumab in steroid-dependent Crohn%26apos;s disease patients: Prognostic factors for clinical benefit
Adalimumab: A Review in Chronic Plaque Psoriasis
Adalimumab for the treatment of refractory noninfectious paediatric uveitis
Adalimumab for the treatment of non-infectious uveitis: an updated review
Adalimumab in Chronic Plaque Psoriasis: A Clinical Guide
Adalimumab: A Review in Hidradenitis Suppurativa
Adalimumab drug survival in patients with psoriasis, Crohn%26apos;s disease, and rheumatoid arthritis: Relevant differences using the same treatment
Adalimumab for the treatment of hidradenitis suppurativa/acne inversa
Adalimumab for juvenile idiopathic arthritis-associated uveitis
Adalimumab Treatment in Biologically Naive Crohn%26apos;s Disease: Relationship with Ectopic MUC5AC Expression and Endoscopic Improvement
Adaline and its application in power quality disturbances detection and frequency tracking
Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial
Adalimumab for childhood onset uveitis
Adalimumab Treatment in Patients with Vogt-Koyanagi-Harada Disease
Adalimumab in Crohn's disease and symptomatic small bowel strictures
Adalimumab as a successful treatment for acne fulminans and bilateral acute sacroiliitis with hip synovitis complicating isotretinoin therapy
Adalimumab concentration-based tapering strategy: as good as the recommended dosage
Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn's Disease: A Pooled Analysis of 11 Clinical Studies
Adalimumab therapy in hepatitis B virus-negative polyarteritis nodosa
Adalimumab and postoperative complications of elective intestinal resections in Crohn's disease: a propensity score case-matched study
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behcet's Syndrome A Retrospective Study of Seventy Patients With Vascular Involvement
Adalimumab for Corticosteroid and Infliximab-Resistant Immune Reconstitution Inflammatory Syndrome in the Setting of TB/HIV Coinfection
Adam10 Is Essential for Early Embryonic Cardiovascular Development
Adamantan-1-aminium p-toluenesulfonate
Adamantyl derivatives of pyrogallol
Adamantane- and Oseltamivir-Resistant Seasonal A (H1N1) and Pandemic A (H1N1) 2009 Influenza Viruses in Guangdong, China, during 2008 and 2009
Adamantane and oseltamivir dual resistance in seasonal influenza A (H1N1) viruses
Adamantylation of 1- and 2-naphthols with 1-adamantanol in trifluoroacetic acid
Adamantane-resistant influenza infection during the 2004-05 season
Adamantane-1-ammonium benzoate
Adams' inequalities for bi-Laplacian and extremal functions in dimension four
Adamantyl-substituted retinoid-derived molecules that interact with the orphan nuclear receptor small heterodimer partner: Effects of replacing the 1-adamantyl or hydroxyl group on inhibition of cancer cell growth, induction of cancer cell apoptosis, and inhibition of Src homology 2 domain-containing protein tyrosine phosphatase-2 activity
Adamantinoma: A clinicopathological review and update
Adams-Oliver syndrome: A sporadic occurrence with minimal disease expression
Adams type inequalities and related elliptic partial differential equations in dimension four
Adamantyl-terminated dendronized molecules: synthesis and interaction with beta-cyclodextrin-functionalized poly(dimethylsiloxane) interface
Adams Predictor-Corrector Systems for Solving Fuzzy Differential Equations
Adams simulation analysis of motion characteristic of passive rimless-wheel
阿达木单抗治疗类风湿关节炎的疗效和安全性
Adams与Simulink的分布式协同仿真
阿达木单抗治疗对类风湿关节炎患者生存质量的影响
Adams谱序列上的一个非平凡积h_0b_1δ_(s+4)(英文)
阿达木单克隆抗体治疗酷似反应性关节炎的强直性脊柱炎一例
阿达木单抗治疗克罗恩病的研究进展
阿达木单抗在类风湿关节炎治疗中的应用
阿达木单抗治疗风湿病的疗效评价
阿达玛变换光谱显微成像分析乳腺癌组织肿瘤标志物的分布